All In Biotech

Drug Trial Radar · NCT00166244

Fixed Dose MMF vs Concentration Controlled MMF After Renal Transplantation

An Open, Prospective, Randomised, Controlled, Multi-Center Study Comparing Fixed Dose vs Concentration Controlled Mycophenolate Mofetil Regimens for de Novo Patients Following Transplantation

Last checked: Nov 19, 2026Latest source record: Feb 12, 2009 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 901 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

901

Actual

Start

May 2003

Primary completion

Mar 2005

Study completion Apr 2006

Sponsor

Lead sponsor
Erasmus Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Hoffmann-La Roche
First posted
Sep 14, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 2 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Determine the value of a clinically feasible strategy of therapeutic drug monitoring compared with fixed dosing in de novo MMF treated renal transplant recipients with respect to the incidence of treatment failure.

Conditions

  • De Novo Renal Transplant Recipient.

Interventions

  • Mycophenolate MofetilDrug

    1 g for adult patients and 300 mg/m2 for paediatric patients. Fixed dose arm: 1 g twice a day (bid) for adults and 600mg/m2 bid for paediatric patients. Concentration controlled arm: initial dose will be 1 g bid for adults and 600mg/m2 bid for paediatric patients. Abbreviated AUCs (taken at timepoints: 0, 30min and 120min in fasted patients) on Days 3 and 10, Week 4, Months 3, 6 and 12 will be performed to determine mycophenolic acid levels in plasma.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Treatment failure including the occurrence of the first one of any of the following: biopsy-proven acute rejection, graft loss, death or discontinuation of MMF therapy during the first 12 months following transplantation.Time frame: 12 Months

Locations

67 sites in 19 countries. Site status is shown where the registry gives one.

  • John Hunter Hospital

    New Lambton, New South Wales, Australia

  • Princess Alexandra Hospital

    Brisbane, Queensland, Australia

  • Monash Medical Centre

    Clayton, Victoria, Australia

  • St Vincent's Hospital

    Melbourne, Victoria, Australia

  • Royal Melbourne Hospital

    Parkville, Victoria, Australia

  • Sir Charles Gairdner Hospital

    Nedlands, Western Australia, Australia

  • Royal Perth Hospital

    Perth, Western Australia, Australia

  • Med. Univ. Klinik

    Graz, Austria

  • AKH Wien

    Vienna, Austria

  • University Hospitals Leuven

    Leuven, Belgium

  • Hospital do Rim e Hipertensao

    São Paulo, Brazil

  • Vancouver General Hospital

    Vancouver, British Columbia, Canada

  • Ruijin Hospital

    Shanghai, Shanghai Municipality, China

  • West China Hospital of Sichuan University

    Chengdu, Sichuan, China

  • Odense University Hospital

    Odense, Denmark

  • Surgical Clinic Of Tartu University Clinics

    Tartu, Estonia

  • Hopital Pellegrin, C.H.R.de Bordeaux

    Bordeaux, France

  • Hospital du Bocage

    Dijon, France

  • CHU de Grenoble

    Grenoble, France

  • CHU Kremlin Bicêtre

    Le Kremlin-Bicêtre, France

  • Hopital Calmette

    Lille, France

  • Hopital Jeanne de Flandres

    Lille, France

  • Centre Hospitalier Regional Universitaire

    Limoges, France

  • CHU Hotel Dieu

    Nantes, France

  • Hopital Necker

    Paris, France

  • Hopital Tenon

    Paris, France

  • Centre Hospitalier Lyon Sud

    Pierre-Bénite, France

  • Hopital Foch

    Suresnes, France

  • CHU Purpan

    Toulouse, France

  • CHU Rangueil

    Toulouse, France

  • CHU de Nancy-Brabois

    Vandœuvre-lès-Nancy, France

  • Universitatsklinikum Charite

    Berlin, Germany

  • Stadt Kliniken Koln

    Cologne, Germany

  • Chirurgische Universitätsklinik

    Freiburg im Breisgau, Germany

  • Universitatsklinikum Heidelberg

    Heidelberg, Germany

  • University of Heidelberg

    Heidelberg, Germany

  • University Hospital Wurzburg

    Würzburg, Germany

  • Vilnius University Hospital

    Vilnius, Lithuania

  • Leids Universitair Medisch Centrum

    Leiden, Netherlands

  • Erasmus Medical Center Rotterdam

    Rotterdam, Netherlands

Showing 40 of 67 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.